The largest database of trusted experimental protocols

Halt protease inhibitor

Manufactured by Thermo Fisher Scientific
Sourced in United States, Germany, Canada

Halt protease inhibitor is a laboratory product designed to inhibit the activity of proteases, which are enzymes that break down proteins. It provides a reliable and effective way to preserve protein integrity during sample preparation and analysis. The core function of Halt protease inhibitor is to prevent the degradation of target proteins, allowing for accurate and reliable results in various biochemical and molecular biology applications.

Automatically generated - may contain errors

338 protocols using halt protease inhibitor

1

Macrophage and HeLa Cell Lysis and Protein Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW 264.7 macrophage-like cells (ATCC tib-71; ATCC, Manassas, VA) were cultured in Dulbecco’s modification of Eagle’s medium, whereas HeLa cells (ATCC ccl-2) were cultured in minimal essential medium; both cell lines were supplemented with 10% fetal bovine serum, 100 IU/ml penicillin, and 100 µg/ml streptomycin. Cells were maintained in an atmosphere of 95% humidity and 5% CO2 at 37°C before passage 15. Cells were harvested in a reaction mixture consisting of phosphate-buffered saline (PBS) containing 1% Triton X-100, 1× HALT protease inhibitor (Thermo Scientific, Rockford, IL), 5 mM EDTA, and 20 mM sodium orthovanadate or of 50 mM HEPES containing 1% Triton X-100, 1× HALT protease inhibitor, 5 mM EDTA, 5 mM N-ethylmaleimide (NEM), and 0.5 mM Tris(2-carboxyethyl)phosphine (TCEP) for SseL pulldown. Proteins were extracted by sonication at 100% amplitude using pulses of on/off cycles of 0.5 s each for 3 repetitions at 30 s per repetition along with vigorous vortex mixing. The crude lysate was clarified by centrifugation at 10,000 × g for 15 min at 4°C, snap frozen in liquid N2, and stored at −80°C.
+ Open protocol
+ Expand
2

Purification of MBP-PTBP3 Fusion Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
MBP-PTBP3 fusion protein was expressed in BL21(DE3) E. coli (New England Biolabs) transformed with pET:THMT:PTBP3 (empty plasmid from Peti and Page, 2007 ) at 15°C overnight with 400 µM IPTG (Sigma).
Induced pellets were resuspended in low imidazole purification buffer [20 mM sodium phosphate (pH 7.4), 1 M NaCl, 10 mM imidazole, and 1´ Halt protease inhibitors (ThermoFisher)] and lysed via sonication.
The suspension was cleared by centrifugation at 28,960 RCF for 30 min. at 4°C, and the resulting supernatant was bound to Ni-NTA resin (Qiagen) for 1 hour at 4°C, washed in 5 bed volumes of low imidazole purification buffer, and eluted in high imidazole purification buffer [20 mM sodium phosphate (pH 7.4), 1 M NaCl, 300 mM imidazole, and 1´ Halt protease inhibitors (Thermo)]. Fractions containing MBP-PTBP3 were pooled, concentrated, buffer exchanged into storage buffer [20 mM sodium phosphate (pH 7.4), 250 mM NaCl], and flash frozen.
+ Open protocol
+ Expand
3

Western Blot Analysis of Akt and 4E-BP1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein expression was performed using Western blot analysis. Briefly, cells were lysed in RIPA buffer including Halt protease inhibitor (Fisher Scientific, Hanover Park, IL; 87785) and subjected to electrophoresis using 12% polyacrylamide gels (Bio-Rad, Hercules, CA; 4568044). Proteins were transferred onto a 0.45 μm polyvinylidene difluoride (PVDF) membrane (Fisher Scientific, Hanover Park, IL; IPVH0010). Membranes were blocked in 5% BSA and immunoblotted with Akt (Cell Signaling Technologies, Danvers, MA; 9272), 4E-BP1 (Cell Signaling Technology; 9644), p-4E-BPl (Cell Signaling Technologies; 9451), p-Akt (Ser473) (Affinity; AF0016), and GAPDH (Life Technologies; 398600). HRP-conjugated secondary antibodies (Cell Signaling Technologies; 7074) were used, and protein levels were visualized using enhanced chemiluminescence (ECL) (Bio-Rad; 1705060)
+ Open protocol
+ Expand
4

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Soluble protein extraction from HEK293T cells was performed using Cytobuster Protein Extraction Reagent (Fisher Scientific) according to the manufacturer’s instructions. Protein extraction solutions were supplemented with 1X Halt Protease Inhibitor (Fisher Scientific) and 1X Halt Phosphatase Inhibitor (Fisher Scientific) Cocktails. Protein concentrations were determined using A280 on a NanoDrop 1,000 Spectrophotometer and subsequently analyzed by Western immunoblotting. Equivalent amounts of protein (40 µg) were separated by 10% SDS-PAGE and transferred to PVDF membranes (Millipore Sigma) using the Trans-Blot Semi-Dry Electrophoretic Transfer Cell System (Bio-Rad); Ponceau S staining was used to assess the equivalency of protein loading after SDS-PAGE transfer. Membranes were washed with 1.0M Tris-buffered saline (TBS), pH 7.4, blocked with 5% Bovine Serum Albumin (BSA) in TBS for 1 hour at room temperature, and then incubated with primary antibodies (Key Resources Table) in 5% BSA in TBS-T (0.1% Tween 20) overnight at 4°C. Following TBS-T washes, membranes were incubated with peroxidase-conjugated secondary antibodies in TBS-T (Key Resources Table) and protein bands were detected using Clarity Western ECL Substrate (Bio-Rad) and visualized using the ChemiDoc Imaging System (Bio-Rad).
+ Open protocol
+ Expand
5

Protein Extraction from Frozen Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen tissue samples were embedded in Cryoembedding Medium (Medite, Germany) and cut into 20 μm sections using a CryoStar NX70 cryostat (Fisher Scientific, Schwerte). For protein analysis by ELISA, tissue slices were incubated on ice for 30–60 min in 1xLM lysis buffer from NADH dehydrogenase (Complex I) Human SimpleStepTM ELISA kit (Abcam, ab178011). Buffers were added in complete mini Protease Inhibitor Cocktail (Roche, Germany), HALT Protease inhibitor (Fisher Scientific, Germany) and Phosphatase inhibitor cocktails 2 and 3 (Sigma, Germany). Lysates were vortexed before centrifugation for 10 min at 13,000 × g to precipitate tissue debris. Supernatants were aliquoted and stored at −80 °C until analysis. Protein concentration was determined using the bicinchoninic acid (BCA) protein assay (Sigma, Germany).
+ Open protocol
+ Expand
6

Seminal PSA Purification and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seminal PSA was purchased from Calbiochem (San Diego, CA). The WHO International Standard PSA Free (NIBSC code 96/668) was obtained from National Institute for Biological Standards and Control (Herts, UK). Seminal PSAs were purified from seminal plasma of healthy men and were used as normal control. Synthetic peptides IRNKS and IRDKS were obtained from BEX Co. Ltd. (Tokyo). Bovine serum albumin (BSA) and phenylmethylsulfonyl fluoride (PMSF) were purchased from Merck (Darmstadt, Germany) and HaltTM protease inhibitor was obtained from Thermo Fisher Scientific (Rockford, IL).
+ Open protocol
+ Expand
7

ECM Protein Quantification in HTM Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HTM cells (N17TM-2, N27TM-2 and N27TM-6) were plated into 96 well plates at 15,000 cells per well. One week after the cells reached confluency media was replaced with media containing 1% FBS and 2ng/ml TGFβ2 with and without 2μM FUD. Two days later the cells were processed for OCW analysis as previously described [19 (link)]. Briefly, cells were extracted with a hypotonic buffer (20mM HEPES, pH 7.4, 1mM EDTA, 1% sodium deoxycholate and HALTTM protease inhibitor (Thermo Fisher Scientific)) leaving behind insoluble extracellular matrix (ECM). The DOC insoluble ECM was fixed with 4% paraformaldehyde and the total protein in the wells was labeled with IRDye 680 NHS ester (LI-COR). Wells were then blocked and fibronectin was detected using rabbit anti-fibronectin sera followed by the IRDye 800CW-conjugated goat anti-rabbit IgG (LI-COR). The plates were then read on a LI-COR Odyssey CLx scanner and analyzed using the LI-COR Image Studio v. 5.0.21 software. The antibody signal was normalized to the corresponding NHS ester signal (total protein).
+ Open protocol
+ Expand
8

Anaerobic Growth of Desulfovibrio and E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
Desulfovibrio sp. strain DF1 and E. coli were grown anaerobically in a carbonate-buffered minimal medium reduced with 1 mM Titanuim(III)nitriloacetate (Ti(III)-NTA) (basal medium, Widdel and Pfennig, 1981 (link); trace elements solution, Widdel et al., 1983 (link); Ti(III)NTA solution, Moench and Zeikus, 1983 (link); selenium-tungstate solution, Tschech and Pfennig, 1984 (link); vitamin solution, Pfennig, 1978 (link)) and 12 mM SQ or 6 mM glucose (E. coli) or 10 mM DHPS (Desulfovibrio sp.). For sulfate-respiring growth conditions, Desulfovibrio sp. DF1 was grown with 10 mM lactate as the carbon source and electron donor and 20 mM sulfate as the terminal electron acceptor. The gas phase was 20% CO2 and 80% N2. All cultures were incubated at 30°C. Cultures for proteomic analysis, 2D-PAGE and enzyme assays in cell-free extracts were harvested in late exponential phase at an optical density (OD580) of about 0.4. The cells were resuspended in 50 mM Tris–HCl buffer, pH 8.0, containing 5 mM MgCl2, 1.7 μg/ml DNAse I and 1× HaltTM protease inhibitor (ThermoFisher Scientific) and disrupted in a cooled French pressure cell.
E. coli for cloning and overexpression was grown in LB medium with, if necessary, 30 μg/ml kanamycin, 100 μg/ml ampicillin or 35 μg/ml chloramphenicol, aerobically on an orbital shaker at 37 or 15°C. For details on the cloning, see below.
+ Open protocol
+ Expand
9

EV Isolation and Characterization from Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
NCI-60 and MCF10a EVs were processed as previously described in great detail [40 (link),43 (link)]. The enrichment efficacy and purity of samples has been demonstrated numerous times through nanoparticle tracking, immunoblot analysis, and electron microscopy by our laboratory [43 (link),44 (link),45 (link),46 (link),47 (link)]. Briefly, serum-free cell-conditioned medium was aspirated from cell culture plates in three biological replicates, and centrifuged at 500× g for 5 min, then at 2000× g for 30 min before incubation overnight with a 1:1 volume of 2X PEG solution (16% (w/v) polyethylene glycol, 1 M NaCl). Following the polyethylene glycol incubation, samples were centrifuged at 3214× g for 60 min, and pellets were resuspended in PBS for an ultracentrifugation purification step (100,000× g for 70 min). Final pellets were lysed in strong lysis buffer (5% SDS, 10 mM EDTA, 120 mM Tris-HCl pH 6.8, 2.5% β-mercaptoethanol, 8 M urea) with the Halttm protease inhibitor (ThermoFisher, Waltham, MA, USA, 78438) added. Vesicle protein quantification was performed using the fluorescence-based EZQ™ Kit (ThermoFisher, Waltham, MA, USA, R33200) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
10

T Cell Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were stimulated by plate-bound antigen in 96 wells. For each condition, 2 × 105 T cells were plated per well in 4 to 6 replicates. Plates were centrifuged at 400g for 1 minute and incubated at 37°C for 30 minutes. Plates were placed on ice to arrest signaling, and cells were collected, washed, and lysed with NP40 (Invitrogen) supplemented with HALT TM protease inhibitor (Thermo Fisher Scientific) and phosphatase inhibitor (Thermo Fisher Scientific). An equal amount of protein lysate was loaded into 4% to 15% Mini-PROTEAN gels (Bio-Rad) and transferred onto PVDF using the Trans-Blot Turbo transfer system (Bio-Rad). Membranes were blocked and stained in EveryBlot Blocking Buffer (Bio-Rad). Primary antihuman antibodies were purchased from Cell Signaling unless specified: CD247 (8D3, BD Biosciences), CD247 pTyr142 (K25-407.69, BD Biosciences), PLCg (D9D6E), PLCg pTyr783 (D6M9S), SLP76 (D1R1A), SLP76 pSer376 (D9D6E), extracellular signal-regulated kinase (ERK) (137F5), and ERK pThr202/Tyr204 (D13.14.4E).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!